Earnings calendar/VRTX
Vertex Pharmaceuticals Incorporated (VRTX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Aug 3, 2026
Consensus estimate row
EPS target
$4.74
Street estimate
Revenue target
$3.23B
Street estimate
Trailing EPS (avg 4Q)
$4.71
Beat rate last 4: 75%
Latest EPS YoY
+10.1%
vs 2025-05-05
Latest revenue YoY
+7.8%
How results look so far
Trailing revenue (avg 4Q)
$3.05B
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
May 4, 2026
EPS beat
EPS actual / est
$4.47 / $4.24
+5.4%
Revenue actual / est
$2.99B / $2.99B
-0.2%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 8/3/2026upcoming | $4.74 | Pending | — | $3.23B | Pending | — |
| 5/4/2026 | $4.24 | $4.47 | +5.4% | $2.99B | $2.99B | -0.2% |
| 2/12/2026 | $5.11 | $5.03 | -1.6% | $3.18B | $3.19B | +0.2% |
| 2/9/2026upcoming | $4.98 | Pending | — | — | Pending | — |
| 11/3/2025 | $4.57 | $4.80 | +5.0% | $3.06B | $3.08B | +0.6% |
| 8/4/2025 | $4.29 | $4.52 | +5.4% | $2.91B | $2.96B | +2.0% |
| 5/5/2025 | $4.25 | $4.06 | -4.5% | $2.86B | $2.77B | -3.2% |
| 2/10/2025 | $4.02 | $3.98 | -1.0% | $2.78B | $2.91B | +4.6% |
| 11/4/2024 | $4.14 | $4.38 | +5.8% | $2.69B | $2.77B | +3.2% |
| 8/1/2024 | $-11.63 | $-12.83 | -10.3% | $2.66B | $2.63B | -1.1% |
| 5/6/2024 | $4.06 | $4.76 | +17.2% | $2.58B | $2.69B | +4.1% |
| 2/5/2024 | $4.10 | $4.20 | +2.4% | $2.51B | $2.52B | +0.2% |
| 11/6/2023 | $3.97 | $4.08 | +2.8% | $2.50B | $2.48B | -0.6% |
| 8/1/2023 | $3.88 | $3.89 | +0.3% | $2.42B | $2.49B | +3.0% |
| 5/1/2023 | $3.00 | $3.05 | +1.7% | $2.34B | $2.37B | +1.6% |
| 2/7/2023 | $3.51 | $3.76 | +7.1% | $2.30B | $2.30B | -0.1% |
| 10/27/2022 | $3.64 | $4.01 | +10.2% | $2.23B | $2.33B | +4.7% |
| 8/4/2022 | $3.48 | $3.60 | +3.4% | $2.13B | $2.20B | +3.0% |
| 5/5/2022 | $3.49 | $3.52 | +0.9% | $2.07B | $2.10B | +1.1% |
| 1/26/2022 | $3.30 | $3.37 | +2.1% | $2.00B | $2.07B | +3.5% |